<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Diffuse large B cell lymphoma: Management of second or later relapse in medically-fit patients</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Diffuse large B cell lymphoma: Management of second or later relapse in medically-fit patients</h1>
<div class="graphic"><div class="figure"><div class="ttl">Diffuse large B cell lymphoma: Management of second or later relapse in medically-fit patients</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm should be used with related UpToDate topics for diagnosis, staging, and management of relapsed or refractory DLBCL. Treatment of CNS involvement should be initiated prior to systemic therapy. Refer to related topic for selection of CAR-T cell, BiTE, and other antibody-based agents.</div><div class="graphic_footnotes"><p>DLBCL: diffuse large B cell lymphoma; CAR-T cell: chimeric antigen receptor T cell; BiTE: bispecific T cell engager antibody; CNS: central nervous system; HCT: hematopoietic cell transplantation.</p>
<p>* If CAR-T cell therapy is not available, autologous HCT is acceptable if not previously performed; if autologous HCT was previously performed, proceed to BiTE or other antibody-based treatment.</p>
    
    Â¶ Choice of BiTE (eg, glofitamab, epcoritamab) or other antibody-based therapy (eg, tafasitamab, polatuzumab, loncastuximab) is based on availability and clinician/institutional experience; autologous HCT is acceptable if not previously performed.</div><div id="graphicVersion">Graphic 142190 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
